134 related articles for article (PubMed ID: 9356783)
21. Response of blood pressure to maximum exercise in hypertensive patients under different therapeutic programs.
de Queiroz Carreira MA; Ribeiro JC; Caldas JA; Tavares LR; Nani E
Arq Bras Cardiol; 2000 Oct; 75(4):281-8. PubMed ID: 11058925
[TBL] [Abstract][Full Text] [Related]
22. [Disturbances in aggregability of red blood cells in essential hypertension].
Korbut RA; Adamek-Guzik T
Folia Med Cracov; 2005; 46(1-2):3-19. PubMed ID: 17037284
[TBL] [Abstract][Full Text] [Related]
23. The importance of blood pressure control.
Jarvis SC
Prof Nurse; 2004 Nov; 20(3):48. PubMed ID: 15552441
[No Abstract] [Full Text] [Related]
24. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
[TBL] [Abstract][Full Text] [Related]
25. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
[TBL] [Abstract][Full Text] [Related]
26. Drug therapy for hypertension in hemodialysis patients.
Hörl MP; Hörl WH
Semin Dial; 2004; 17(4):288-94. PubMed ID: 15250920
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
28. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
29. Cytosolic calcium and hemorheological patterns during arterial hypertension.
Cicco G; Carbonara MC; Stingi GD; Pirrelli A
Clin Hemorheol Microcirc; 2001; 24(1):25-31. PubMed ID: 11345231
[TBL] [Abstract][Full Text] [Related]
30. Hemorheological changes after intravenous gammaglobulin administration in patients with neurological disorders.
Kowal P; Zmyślony A
Clin Hemorheol Microcirc; 2008; 40(3):229-34. PubMed ID: 19029646
[TBL] [Abstract][Full Text] [Related]
31. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
[TBL] [Abstract][Full Text] [Related]
32. The effect of diuretics on red blood cell microrheological parameters in female hypertensive patients.
Muravyov AV; Yakusevich VV; Kabanov AV; Petrochenko AS
Clin Hemorheol Microcirc; 2005; 33(2):121-6. PubMed ID: 16151259
[TBL] [Abstract][Full Text] [Related]
33. [Treatment patterns of hypertension in 1996. Data from the Quebec Family Practice, University of Sherbrooke registry].
Laplante P; Niyonsenga T; Delisle E; Vanasse N; Vanasse A; Grant AM; Xhignesse M
Can Fam Physician; 1998 Feb; 44():306-12. PubMed ID: 9512834
[TBL] [Abstract][Full Text] [Related]
34. Impact of ASCOT on hypertension treatment and guidelines in older adults.
Sheridan R; Baldwin N
Age Ageing; 2006 May; 35(3):214-7. PubMed ID: 16638764
[No Abstract] [Full Text] [Related]
35. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
36. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
Rosolová H; Cech J; Sefrna F
Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
[TBL] [Abstract][Full Text] [Related]
37. [Hemorheologic changes in patients with essential hypertension treated with prazosin].
Gerc V; Koblar V; Brkić D; Kamhi J
Med Pregl; 1992; 45(7-8):285-7. PubMed ID: 1344459
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effect of alpha-blocker on hemorheology in patients with essential hypertension.
Gomi T; Ikeda T; Ikegami F
Am J Hypertens; 1997 Aug; 10(8):886-92. PubMed ID: 9270083
[TBL] [Abstract][Full Text] [Related]
39. [Modification of hemorheologic parameters by beta-receptor blockers with special reference to propranolol and talinolol].
Böhme HR; Neupert A; Fischer W
Z Gesamte Inn Med; 1988 Aug; 43(16):450-4. PubMed ID: 2903595
[TBL] [Abstract][Full Text] [Related]
40. [Hemorheologic effects of calcium antagonists in comparison with beta receptor blockers].
Ernst E
Z Kardiol; 1989; 78 Suppl 5():12-5. PubMed ID: 2576578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
